Three-dimensional (3D) Printed Hemodialysis Vascular Model
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Oct 15, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help doctors plan for surgeries related to hemodialysis access, which is the method used to get blood from your body to a dialysis machine. The goal is to create a three-dimensional (3D) printed model of the blood vessels where the hemodialysis access is placed. This model can help doctors prepare better and reduce the chances of complications, like infiltration, which is when the access point does not work properly, leading to more hospital visits.
To be eligible for this trial, participants should be patients who have had a hemodialysis access placed surgically and have used it in the last 90 days, or are getting ready to use it in the next 90 days. Unfortunately, if someone only has a failed access that hasn’t been used for over 90 days, they would not be able to participate. If you join this study, you will be part of a process that could improve the way doctors perform these important procedures, helping to make dialysis treatment safer and more effective for everyone involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a surgically placed hemodialysis access which has been used in the last 90 days or is being prepared for use in the next 90 days
- Exclusion Criteria:
- • Patients with only failed hemodialysis surgical access(es) that has/have not been used for \>90 days.
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Andrew Siedlecki, MD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials